An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies by Alexander Mazein, Oxana Lopata, Kristin Reiche, Kristin Reiche, Kristin Reiche, Katherina Sewald, Katherina Sewald, Miriam Alb, Christina Sakellariou, Patricia Gogesch, Hannah Morgan, Vanessa Neuhaus, Vanessa Neuhaus, Nhu-Nguyen Pham, Nhu-Nguyen Pham, Charline Sommer, Charline Sommer, Ethan Perkins, Ethan Perkins, Birgit Fogal, Muhammad Shoaib, Reinhard Schneider, Reinhard Schneider, Venkata Satagopam, Venkata Satagopam, Marek Ostaszewski, Marek Ostaszewski

Get full text

Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies by Frank R. Brennan, J. Ryan Polli, Jean Sathish, Melissa Ramones, Babette Wolf, Tilman Schlothauer, Shirley J. Peters, Curtis C. Maier, Changhua Ji, David L. Wensel, Derrick Witcher, Patricia C. Ryan, T. Scott Manetz, Adriano Flora, Brian Soper, Birgit Fogal, Lindsey Dzielak, Xiaoting Wang, Prathap Nagaraja Shastri, Karen Price, Michael Doyle, Nidhi Sharda, Mary Struthers, Maximilian Brinkhaus, Bianca Balbino, Eric Stefanich, Masaki Honda, Jan Terje Andersen, Shermaine Mitchell-Ryan, David P. Humphreys

Get full text